Actively Recruiting
A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection
Led by Invenio Imaging Inc. · Updated on 2025-07-01
900
Participants Needed
7
Research Sites
4 weeks
Total Duration
On this page
Sponsors
I
Invenio Imaging Inc.
Lead Sponsor
M
Memorial Sloan Kettering Cancer Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to evaluate deep learning algorithms designed to detect suspicious cell and tissue patterns for cancer in biopsies taken from peripheral lung nodules, masses, and mediastinal or hilar lymph nodes. The study uses the NIO Laser Imaging System during bronchoscopy procedures to image samples without traditional processing. It is a prospective, observational study focusing on rapid lung cancer detection with artificial intelligence assistance. The study includes four groups based on biopsy location and method: transbronchial forceps biopsy of peripheral lung nodules/masses, transbronchial needle aspiration biopsy of peripheral lung nodules/masses, transbronchial needle aspiration biopsy of mediastinal/hilar lymph nodes, and transbronchial cryo biopsy of peripheral lung nodules/masses. Each biopsy procedure is performed as part of routine clinical care, and imaging is done in the procedure room using the NIO Laser Imaging System. Participants are adults scheduled for clinically indicated lung biopsies with an intermediate to high likelihood of lung cancer. The study tracks outcomes from enrollment until the end of each biopsy procedure. Researchers will assess how well the deep learning algorithms identify suspicious morphology during the procedure. Participants will be monitored during their procedures, and data will be collected to validate the technology's performance in detecting cancerous changes.
CONDITIONS
Brief Title
A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient or legal guardian is willing and able to understand, sign, and date the informed consent form.
- Patient is 22 years of age or older.
- Patient is scheduled for routine mediastinal staging (EBUS-TBNA) and peripheral lung biopsy with intermediate to high suspicion of lung cancer.
- Patient can tolerate the indicated clinical procedure.
You will not qualify if you...
- Patient is a prisoner.
- Investigator judges the participant as inappropriate for the intended study procedures.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Day of the procedure
Participants undergo routine bronchoscopy procedures including mediastinal staging and peripheral lung biopsy to aid in lung cancer detection.
1 visit (in-person)
Trial Site Locations
Total: 7 locations
1
UC San Diego
San Diego, California, United States, 92037
Actively Recruiting
2
Mayo Clinic Jacksonville
Jacksonville, Florida, United States, 32224
Not Yet Recruiting
3
Corewell Health
Grand Rapids, Michigan, United States, 49503
Actively Recruiting
4
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Suspended
5
Montefiore Medical Center
The Bronx, New York, United States, 10467
Actively Recruiting
6
UNC Medical Center
Chapel Hill, North Carolina, United States, 27514
Actively Recruiting
7
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Active, Not Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here